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Key points  
 The contribution of HCN4 pacemaker channels in the autonomic regulation of sino-atrial node 
(SAN) has been a matter of debate.  
 The transgenic overexpression of HCN4 did not induce tachycardia, but reduced heart rate variability, 
while the conditional knockdown of HCN4 gave rise to sinus arrhythmia. 
 The response of SAN to -adrenergic stimulation was not affected by overexpression nor knockdown 
of HCN4 channels. 
 When HCN4 channels were knocked down, the parasympathetic response examined by cervical 
vagal nerve stimulation (CVNS) was enhanced; the CVNS induced complete sinus pause. The 
overexpression of HCN4 attenuated bradycardia induced by the CVNS, only during the -adrenergic 
stimulation. 
 We concluded that HCN4 pacemaker channels stabilize the spontaneous firing by attenuating 
parasympathetic response of SAN.  
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Abstract  
The heart rate is dynamically controlled by the sympathetic and parasympathetic nervous systems that 
regulate the sinoatrial node (SAN). HCN4 pacemaker channels are well-known causative molecule of 
congenital sick sinus syndrome. Although HCN4 channels are activated by cAMP, the sympathetic 
response of SAN was preserved in the patients carrying loss-of-function mutations of HCN4 gene. In 
order to clarify the contribution of HCN4 channels in the autonomic regulation of SAN, we developed 
novel gain-of-function mutant mice in which expression level of HCN4 channels could be reversibly 
changed from zero to ~3 times of that in wild type mice, using tetracycline trans-activator and tetracycline 
responsive element. Then, we recorded telemetric ECGs in free moving conscious mice, and analysed the 
heart rate variability (HRV). We also evaluated the response of SAN to cervical vagal nerve stimulation 
(CVNS). The conditional overexpression of HCN4 did not induce tachycardia, but reduced heart rate 
variability. The HCN4-overexpression also attenuated bradycardia induced by the CVNS, only during the 
-adrenergic stimulation. In contrast, the knockdown of HCN4 gave rise to sinus arrhythmia, and 
enhanced the parasympathetic response; complete sinus pause was induced by the CVNS. In vitro, we 
compared the effects of acetylcholine on the spontaneous action potentials of single pacemaker cells, and 
found that the similar phenotypic changes were induced by genetic manipulation of HCN4 expression 
both in the presence and absence of -adrenergic stimulation. Our study suggests that HCN4 channels 
attenuate the vagal response of SAN, and thereby stabilize the spontaneous firing of SAN. 
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Abbreviations 
HCN4   hyperpolarization-activated cyclic nucleotide gated channel 4 
If       funny current 
SAN    sinoatrial node 
SAP     spontaneous action potentials 
GIRK4   G-protein-coupled inward rectifier K+ channels 
tTA      tetracycline trans-activator 
TRE     tetracycline-responsive element 
DOX    doxycycline 
PMC    pacemaker cells 
AVN    atrioventricular node 
CVNS   cervical vagal nerve stimulation 
SDNN   standard deviation of all RR intervals 
RMSSD  root mean square of the difference of successive RR intervals 
CCS     cardiac conduction system 
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Introduction 
Heart rate (HR) regulation is essential for the homeostasis that ensures appropriate cardiac output under 
various physiological conditions. The HR is determined by spontaneous action potentials (SAP) of 
cardiac pacemaker cells in the sinoatrial node (SAN). The automaticity of pacemaker cells originates 
from the slow diastolic depolarization phase. Sympathetic and parasympathetic nerve stimulations change 
the slope of the slow diastolic depolarization in opposite directions, thereby regulating the firing 
frequency of pacemaker cells (Mangoni & Nargeot, 2008). 
The slow diastolic depolarization, also called the pacemaker potential, is generated by two synergic 
mechanisms: the calcium clock and the membrane clock. In the former mechanism, spontaneous Ca2+ 
release from the sarcoplasmic reticulum activates an inward Na+-Ca2+ exchanger current (Lakatta & 
DiFrancesco, 2009; Lakatta et al. 2010). The latter mechanism comprises the sequential activation of 
voltage-gated inward channels; the hyperpolarization-activated cyclic nucleotide gated channels (HCN1, 
HCN2 and HCN4), low-threshold calcium channels (Cav3.2), and dihydropyridine-sensitive calcium 
channels (Cav1.2 and Cav1.3) on the plasma membrane (Mangoni et al, 2003, Mangoni et al. 2006; 
Bucchi et al. 2012; Herrmann et al. 2012; Mesirca et al. 2015). 
In the autonomic regulation of the pacemaker potential, the specific impacts of these molecules are still 
a matter of debate. Amongst them, the “funny” current (If) has been suggested to play a pivotal role 
because If is activated by cAMP (DiFrancesco, 2010). However, loss-of-function studies of HCN4, a 
major subtype responsible for If in the SAN, have demonstrated that HCN4 is not essential for tachycardia 
induced by β-adrenergic stimulation: HCN4-knockout mice developed variable degrees of dysfunction in 
pacemaker automaticity ranging from recurrent sinus pause to lethal bradycardia (Bucchi et al. 2012; 
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Herrmann et al. 2012). Such pacemaker dysfunction was rescued by genetic ablation of 
G-protein-coupled inward rectifier K+ channels (GIRK4) that were activated by M2 muscarinic receptors 
in the SAN (Mesirca et al. 2015). Recent studies have demonstrated that changes in the expression levels 
of HCN channels in the SAN are correlated with basal HR; in pregnant mice, an increase in HCN2 
expression in the SAN gave rise to tachycardia (El Khoury et al. 2013). Exercise training was shown to 
induce sinus bradycardia via down-regulation of HCN4 expression in the SAN (D’Souza et al. 2014).  
These findings suggest that changes in the expression level of HCN channels could modify autonomic 
response as well as basal HR, particularly parasympathetic response of the SAN in both positive and 
negative directions. To test this hypothesis, we employed both gain-of-function and loss-of-function 
approaches; using a TET-off system, we generated novel transgenic mice in which the expression level of 
HCN4 could be changed from zero to ~3 times that found in wild types (Nakashima et al. 2013). Using 
this system, we performed telemetric ECG recordings, the HRV analysis, and cervical vagal nerve 
stimulation, as well as patch clamp experiments using single pacemaker cells. We will demonstrate that 
HCN4 channels attenuate the parasympathetic response of SAN, and stabilize the spontaneous firing of 
SAN. Preliminary results have been communicated at the Physiological Society of Japan (Kozasa et al. 
2016). 
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Methods 
Ethical approval 
All animal experiments were approved by the Animal Ethics Committee of Kurume University. Animal 
care and experiments conform to the guidelines of the Journal of Physiology (Grundy, 2015). We used 
14-25 weeks old mice of both sex (body weight 20~25 g). After finishing in vivo experiments, the mice 
were deeply anaesthetized with 5.0% sevoflurane in a plastic chamber, and euthanized by quick 
decapitation. 
 
Generation of HCN4
+/tTA_TRE
 mouse 
HCN4+/tTA_TRE was generated as previously reported.15,16 HCN4+/tTA_TRE mice were identified by genomic 
PCR using the forward primer (5’-CGA ATA AGA AGG CTG GCT CTG CAC C-3’) and the reverse 
primer (5’-GAG CAG CCT ACA TTG TAT TGG CAT G-3’). To inhibit HCN4 expression from the 
mutant allele, food pellets containing doxycycline (DOX; 6 mg/g, Research Diet, NJ, USA) were 
provided ad libitum.  
 
Generation of HCN4
+/Luc
 mouse 
To create the 5’ and 3’ homologous arms of the targeting vector, the C57BL/6J mouse genomic DNA 
containing the Hcn4 gene were obtained from a BAC clone (clone ID: RP23-324A14, Roswell Park 
Cancer Institute). The cDNA of a fusion protein of firefly luciferase (U_47298) and EGFP (U_03453.1) 
followed by SV40 polyadenylation signal and a neomycin-resistance gene cassette were inserted in-frame 
into the start codon of the Hcn4 gene. The targeting vector was linearized by a SalI site and 
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electrophoresed into C57BL/6J embryonic stem cells. The G418-resistant colonies were picked up and 
screened for homologous recombination by PCR and Southern blot. Chimeras were generated by injecting 
the correctly targeted ES cells into blastocysts of Balb/c mice and were identified by coat colour. 
Chimeric male founder mice were mated to C57BL/6J female mice to generate F1 heterozygous mice for 
the knockin line. F1 heterozygous mice were crossed with CAG-Cre mice to delete the neomycin cassette. 
The HCN4+/luc mice were identified by PCR using the forward primer 5’-CGA GCT GGA CGG CGA 
CGT AAA CGG C-3’ and reverse primer 5’-CAT CCT TAG GGA GAA TTT GTT GAC C-3’. 
 
Quantitative PCR (qPCR) 
Mice were deeply anaesthetized with 3.0% sevoflurane, and the whole hearts were quickly removed 
(n=3 in each strain). Total RNA was obtained from the whole heart using Trizol reagent (Thermo Fisher 
Scientific) following the manufacturer’s instructions. Single strand cDNA was synthetized using 
Superscript III (Thermo Fisher Scientific). The quantitative real-time reverse transcription polymerase 
chain reaction (qPCR) was performed using predesigned TaqMan Gene Expression assays probes 
(Thermo Fisher Scientific): mouse HCN1 (Mm00468832_m1), HCN2 (Mm00468538_m1), HCN3 
(Mm01212852_m1), and HCN4 (Mm01176086_m1). Relative levels of mRNAs were normalized to the 
level of 18S rRNA. 
 
Microarray analysis 
In each strain of mouse, the SAN tissue (1.5×0.5 mm) was collected from 3 hearts. Total RNA was 
isolated using an RNeasy Lipid Tissue Kit (Qiagen, MD, USA). The RNA sample was processed for 
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hybridization on a MouseGene 2.0ST Array (Affymetrix) using a GeneChip WT Plus Reagent Kit 
(Thermo Fisher Scientific). Fold change > ±1.5 was regarded as a significant difference. 
 
Western blotting 
 Western blotting was performed in triplicate. Proteins were extracted from the whole heart and kidney of 
transgenic mice using T-PER Tissue Protein Extraction Reagent (Thermo Fisher Scientific, Waltham, 
MA) following the manufacturer’s instruction. The equal amounts of proteins were separated on 7% 
SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Thermo Fisher Scientific). The 
membranes were incubated with primary anti-Hcn4 polyclonal (1:200, Alomone Labs, Jerusalem, Israel), 
primary anti-β-actin polyclonal antibody (Ab) (1:1000, MBL, Nagoya, Japan), and goat-anti rabbit IgG 
HRP-Ab (1:1000, MBL), or anti-α-tubulin polyclonal Ab-HRP-DirecT (1:1000, MBL). Signals were 
visualized by Immobilon Western HRP Substrate (Millipore, Billerica, MA) and FluorChem FC2 (R&D 
systems, Minneapolis, MN). 
 
Luminescence imaging 
150 µl of XenoLight RediJect D-luciferin (30 mg/ml, ParkinElmer, Waltham, MA, USA) were injected 
into the peritoneal cavity of HCN4+/luc mice. In vivo imaging was performed 15 min after the injection 
using IVIS-100 (ParkinElmer) under general anaesthesia with 1.5% isoflurane. Thereafter, the hearts were 
removed and immersed in nominally Ca2+-free Tyrode solution containing 30 g/ml D-luciferin. The right 
atrium and both ventricles were opened and fixed on silicon rubber. In vitro luminescence images were 
taken by an EM-CCD camera (ImagEM2, Hamamatsu Photonics, Hamamatsu, Japan) on a macro zoom 
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microscope (MV-10; Olympus, Tokyo, Japan) or on a Slice scope (Scientifica, Uckfield, UK) with a water 
immersion objective lens (×40, NA=0.8, Olympus). 
 
Isolation of single pacemaker cell and patch-clamp recordings 
After anaesthetizing with 3.0% sevoflurane, the SAN tissue was excised in pre-warmed (36C) normal 
Tyrode solution containing (in mM): NaCl 140, KCl 5.4, CaCl2 1.8, MgCl2 0.5, NaH2PO4 0.33, HEPES 5, 
and glucose 5.5 (pH = 7.4 with NaOH). The SAN tissue was enzymatically digested for 20 min at 37C in 
nominally Ca2+ free Tyrode solution containing 344 U/ml liberase (Roche Molecular Systems) and 1.9 
U/ml elastase (Worthington Biochemical Corporation, NJ, USA). Single pacemaker cells (PMC) were 
mechanically dissociated from tissue strips in KB solution containing (in mM): glutamic acid 70, KCl 30, 
KOH 70, KH2PO4 10, MgCl2 1, taurine 20, EGTA 0.3, HEPES 10, and glucose 10 (pH = 7.4 with KOH). 
Isolated PMCs were stored in KB solution at 4C before experiments. The membrane current and the 
spontaneous action potentials (SAPs) were recorded using an Axopatch200B amplifier (Molecular Device, 
CA, USA) at 33-35C.  
The If was recorded using the ruptured whole cell patch method in Tyrode solution containing 2 mmol/L 
BaCl2.The resistance of patch electrodes was 2-5 MΩ when filled with standard high K
+ intracellular 
solution containing (in mM): aspartic acid 100, K2-ATP 5, Na2-creatine phosphate 5, EGTA 0.1, KCl 30, 
MgCl2 1, CaCl2 0.04 (pCa=7.0), and HEPES 5 (pH=7.2 with KOH). The voltage dependent activation of 
If was evaluated with the two-step pulse protocol; the amplitudes of the time-dependent If current 
activated by the test pulse (-150 mV) were normalized by their maximal value, and were plotted against 
the preceding conditioning pulses (-50 to -140 mV). We then fitted the Boltzmann’s equation: %activation 
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=1/ (1+exp((V1/2-Vm)/s)), where V1/2 was the voltage for the half-maximal activation; Vm, membrane 
potential; s, slope factor. The diastolic depolarization rate (DDR) of SAPs was calculated as a slope 
between 2 points: the point where dV/dt=0, and the point at two-thirds of the diastolic 
depolarization.  
 
Telemetric ECG recording & HR histogram 
Under general anaesthesia with 1.5% isoflurane, a telemetric transmitter (TA11ETA-F10, DSI, USA) 
was implanted into the subcutaneous pocket with electrodes arranged above and below the heart. After at 
least 8 days of recovery from the surgical stress, the ECG was recorded in a conscious, free-moving 
condition. Mice were kept in an air-conditioned room at 25C under a 12 hours-bright/12 hours-dark 
cycle. Food and water were provided ad libitum.  
The analogue telemetric ECG signals were digitized at 1 kHz and recorded using PONEMAH software 
(DSI, USA). R peaks of the ECG signal were detected, and the mean HR was calculated from the RR 
interval and averaged for 1 min. Values of the mean HR were binned using 70 equally distributed 
windows (bin width; 10 beats/min) in a range from 100 to 800 beats/min. 
 
Analysis of the HRV 
The HRV was analysed at the most frequently observed HR determined by the HR histogram during the 
low activity period. We performed time domain analysis including RR-plot, Poincaré plot, and frequency 
domain analysis. RR-plot: Series of the RR intervals were plotted for 60 s. Poincaré Plot: RR intervals 
(n; abscissa) were plotted against the following RR intervals (n+1; ordinate). The total number of points 
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was 20,000. SDNN and RMSSD: Two-hour ECG traces were selected, and artefact correction was 
performed by excluding the data points outside the mean ± 2SD. Frequency domain analysis: The 
RR-plot was interpolated by cubic spline interpolation at 50 ms intervals to create equidistant points 
suitable for fast Fourier transformation (FFT) using Kubios HRV standard software (Kubios, USA). After 
artefact correction excluding the data points outside the mean ± 2SD, FFT was performed using 2048 
points and a half overlap within a Hanning window, and the power spectral density was calculated. 
 
Vagal nerve stimulation 
Control ECG (lead II) was recorded using PowerLab 26T (ADI Instruments, CO, USA) for 5 min under 
general anaesthesia with 3.0% sevoflurane. Thereafter, the right cervical vagal nerve (CVN) was gently 
detached and ligated with an 8-0 nylon suture. After the HR returned to control levels, the right CVN was 
stimulated at the peripheral side of the ligation with bipolar electrodes (10 V at 20 Hz for 10 s). Body 
temperature was monitored and kept at 37C using a heating pad during the experiment. 
 
Data analysis  
In molecular biological experiments, n denotes the number of samples, and equals the number of 
animals used. In vivo experiment, n is the number of the observations within a single experiment that 
equals the number of animals used. In patch clamp experiments, the membrane current was recorded in 14 
cells isolated from 6 WT mice, 19 cells from 6 OEx mice, and 17 cells from 5 KD mice. Spontaneous 
action potentials (SAP) were recorded; in 11 cells isolated from 4 WT mice, 11 cells from 3 OEx mice, 11 
cells from 4 KD mice in Figure 8; in 7 cells isolated from 3 WT mice, 8 cells from 3 OEx mice, 8 cells 
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from 3 KD mice in Figure 9. The parameters of SAP were averaged from 5 successive SAPs in each 
experimental condition. All data are presented as the mean ± SEM. For multiple comparisons, two-way 
ANOVA followed by the Holm-Sidak’s test was used in Figure 8 and 9. One-way ANOVA followed by 
Dunnett’s test was used in all other experiment. Differences were considered significant when P<0.05. 
Statistical analysis was performed using SigmaPlot 12.5 (Systat software, USA).  
 
Results 
Generation of HCN4-overexpression (OEx) and HCN4-knockdown (KD) mice 
To overexpress HCN4 channels at their physiological expression locus, we inserted a genetic switch 
using a tetracycline trans-activator (tTA)/operator system upstream of the translation initiation site of the 
HCN4 gene as depicted in Figure 1a (Bond et al. 2000; Nakashima et al., 2013).  In this system, the 
HCN4-promoter drives the expression of tTA protein, which activates the transcription of HCN4 from the 
tetracycline-responsive element (TRE)-CMV promoter with high efficiency. Furthermore, the 
transcription of HCN4 could be completely suppressed by doxycycline (DOX), which interferes with the 
binding of tTA to TRE. Therefore, in homozygous HCN4tTA_TRE/tTA_TRE mice, it should theoretically be 
possible to regulate the expression level of HCN4 from zero to several times that of the wild types (WTs). 
However, we could not obtain homozygous HCN4tTA_TRE/tTA_TRE mice, suggesting that excessive 
overexpression of HCN4 may be embryonically lethal for unknown reasons. We also applied DOX to 
HCN4+/tTA_TRE mothers during pregnancy. However, we could not obtain HCN4tTA_TRE/tTA_TRE, probably 
because this mutant administrated DOX shows the similar embryonic lethality reported in HCN4-/- mice 
(Herrmann et al. 2007). Consequently, we used heterozygous HCN4+/tTA_TRE mice as a model of 
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HCN4-overexpression in this study and designated them as OEx mice.  
We also knocked-in cDNA of a fusion protein of firefly luciferase and GFP into the translation initiation 
site of HCN4 (HCN4+/luc; Figure 1a). In this mouse, HCN4 expression from the mutant allele was 
completely inhibited, but the anatomical locus of HCN4 expression could be visualized with 
luminescence derived from the luciferin-luciferase reaction. As shown in Figure 1b, luminescence could 
be observed in the SAN area of right atrial preparations, which was similar to the findings in a previous 
study (Hoesl et al. 2008). As shown in Figure 1c and d, luminescence signal was also detected in the 
Purkinje fibres. In vivo, intense luminescence was also observed, most likely derived from olfactory 
neurons, taste buds, and osteoclasts in Figure 1e. (Stevens et al. 2001; Nakashima et al. 2013; Notomi et 
al. 2015). However, GFP fluorescence was too weak and indistinguishable from the autofluorescent 
signal. 
We next generated double knockin mouse (HCN4
Luc/tTA_TRE
) by crossbreeding HCN4
+/tTA_TRE
 and 
HCN4+/Luc mice. The likelihoods of all possible genotypes were at normal Mendelian rates. All strains of 
HCN4+/luc, HCN4+/tTA_TRE, and HCN4Luc/tTA_TRE mice grew up normally without any apparent behavioural 
disorders. In order to knockdown the expression of the HCN4 protein, we administrated DOX to 
HCN4Luc/tTA_TRE mice. To compare expression levels of HCN4 mRNA, we performed qPCR experiments. 
As shown in Figure 2a, the expression level of HCN4 was about three times higher in OEx mouse hearts 
than in the wild types (WTs) and was almost zero in KD mice after administration of DOX for 2 or 4 
weeks. A lack of the HCN4 protein in KD mice was also confirmed by Western blots (Figure 2b). We 
therefore designated HCN4Luc/tTA_TRE mice administered DOX as HCN4-knockdown; KD mice. On the 
other hand, expression levels of other members of the HCN family (HCN1, 2, and 3) were not altered in 
16 
the hearts of OEx or KD mice (Figure 2a). We also carried out microarray analysis using mRNA isolated 
from the SAN of WT, OEx, and KD mice; we confirmed no significant changes in the expression levels 
of such ion channels, transporters, receptors and related molecules that reportedly participate in the 
regulation of the SAN function as summarized in Table 1 (Posokhova et al. 2013; Sah et al. 2013).  
 
 “Funny” current (If) in pacemaker cells of transgenic mice 
We next compared the densities of “funny” currents (If) in pacemaker cells (PMCs) isolated from the 
SAN of WT, OEx, and KD mice. We selected PMCs based on their morphology and motility (spindle 
cells and elongated cells with spontaneous beating). As shown in Figure 3a, we confirmed luminescence 
signals derived from these types of myocytes isolated from HCN4+/luc mice. The membrane capacitances 
of the PMCs were not significantly different in WT (46.3 +/- 6.9 pF, n=14), OEx (42.3 +/- 4.3 pF, n=19), 
and KD (48.7 +/- 6.4 pF, n=17) mice. The amplitudes of the If, defined as the time-dependent current 
activated by the hyperpolarization, were normalized by the cellular capacitance and plotted in Figure 3c. 
In the PMCs of OEx mice, the densities of the If were significantly larger than those of the WTs between 
-130 mV and -70 mV (Figure 3c, ; -130 mV to -80 mV: P<0.001, -70 mV: P=0.028). The activation 
time course was also slower, indicating the notion that in the PMCs of OEx mice, HCN4, i.e., the most 
slowly activating subtype, was robustly overexpressed. In KD mice, the density of the residual If was 
significantly smaller than that of the WTs at -130 mV, -90 mV, and -70 mV (Figure 3c, ; 
P=0.013~0.022). In this experiment, the amplitude of If may have been overestimated because we 
excluded quiescent PMCs that completely lacked an If, and focused on irregularly beating PMCs, which 
expressed residual HCN1 and HCN2 at relatively higher densities. In line this this notion, the residual If 
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in KD mice showed faster activation time course. These findings well agreed with previous reports 
demonstrating that the residual If of conditional HCN4 knockout mice was mainly due to HCN1 and 
HCN2, whose activation time kinetics are faster than that of HCN4 (Herrmann et al. 2007; Hoesl et al. 
2008; Baruscotti et al. 2011).  
Taken together, the changes in the density of the If in OEx and KD mice were consistent with the 
molecular biological results shown in Figure 1. 
 
HR histogram was altered in telemetric ECG recordings of mutant mice 
Based on the above findings, we next investigated the phenotypic changes in vivo by recording 
telemetric ECG in freely moving, conscious WT, OEx, and KD mice. Contrary to our expectation, no 
apparent tachycardia was observed in OEx mice. KD mice started to exhibit sinus arrhythmia 4-5 days 
after starting DOX administration, and reduction of the HR gradually proceeded. As demonstrated in 
Figure 2a, suppression of HCN4 expression reached a steady state 2 weeks after DOX administration. We 
therefore performed 24 hr telemetric ECG recordings at this time point. Figure 4a shows typical ECG 
traces recorded during the low activity period; both WT and OEx mice showed normal sinus rhythms, 
whereas KD mice showed severe sinus arrhythmia. As summarized in the bar graphs (Figure 4b), PR, 
QRS, and QT intervals were not significantly different, suggesting that electrical conduction in the 
atrioventricular node (AVN) and in Purkinje fibres were not changed in KD or OEx mice. 
In contrast, SAN function represented by HR histograms was clearly different between WT (n=3, grey 
bars), OEx (n=3, blue), and KD (n=3, red) mice, as shown in Figure 4c and d. In the WTs, an HR 
histogram during the high activity period showed two peaks: a slow peak at 480~500 beats/min and a fast 
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peak at 620~640 beats/min. During a low activity period, the fast peak became ambiguous, and only a 
single, broad peak at 440~460 beats/min became evident. The fluctuation range of the HR (difference 
between the minimum and maximum HR) was 330.0±12.3 beats/min in the high activity period and 
338.7±16.5 beats/min in the low activity period. These patterns were similar to the results reported in a 
previous study (Alig et al. 2009; Fenske et al. 2013). 
In OEx mice, the HR histogram in the high activity period showed a single, broad peak at 540~560 
beats/min, and the fluctuation range was 322.7±32.2 beats/min (Figure 4c). In the low activity period, the 
HR histogram also showed a single peak at 460~480 beats/min, and the fluctuation range was 265.7±33.2 
beats/min, which was smaller than that of the WTs. As OEx mice showed no apparent behavioural 
alterations, these changes appeared due to SAN function, rather than physical activity. 
In KD mice, the entire HR histograms shifted to lower values, and the fluctuation range of the HR was 
larger than that of the WTs, both in the high and low activity periods (Figure 4d). These findings were in 
agreement with previous reports on HCN1-, HCN2-, and HCN4-knockout mice (Ludwig et al. 2003; 
Herrmann et al. 2007; Baruscotti et al. 2011; Fenske et al. 2013). It should be noted in particular that 
during the low activity period, KD mice showed severe bradycardia (100~200 beats/min) due to a 
recurrent sinus pause, which was most probably due to the circadian change of autonomic nerve activity. 
 
Beat-to-beat HR variability was reduced by HCN4-overexpression and enhanced by HCN4-knockdown 
The telemetric ECG recordings in the previous section suggested that overexpression of HCN4 as well 
as knockdown of HCN4 could affect autonomic regulation of SAN function. Therefore, we next analysed 
the beat-to-beat HR variability (HRV) in WT, OEx, and KD mice, focusing on the low activity period 
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during which parasympathetic nerve activity was predominant. 
We plotted RR intervals for 1 min at the most frequently observed values of the HR during the low 
activity period: WT, 440~460 beats/min; OEx, 460~480 beats/min; KD, 400~420 beats/min, as indicated 
by the peak of the HR histograms (see Figure 4c and d). As is evident from Figure 5a, b, and c, the 
baseline fluctuation of the RR interval was clearly smaller in OEx mice and larger in KD mice compared 
with the WTs. In all strains of mice, HRV was completely suppressed by an injection of atropine (0.5 
mg/kg, i.p.) and propranolol (5 mg/kg, i.p.), indicating that the fluctuation was due to autonomic 
regulation of the SAN (Figure 5d, e, and f). 
The difference in the HRV was more clearly demonstrated in a Poincaré plot of successive RR intervals. 
Figure 5g shows an oval distribution pattern recorded in WTs as the control. As shown in Figure 5h, the 
plot of OEx mice also demonstrated an oval pattern, although the area of dispersion was smaller than the 
control plot, indicating that the beat-to-beat fluctuation was reduced in OEx mice. In accordance with this, 
the standard deviation of all RR intervals (SDNN), and the root mean square of the difference of 
successive RR intervals (RMSSD) were significantly decreased in OEx (Figure 6a). In contrast, the 
Poincaré plot of KD mice shown in Figure 5i demonstrated a widely spread comet pattern. Similar 
findings were also reported in patients carrying HCN4 mutations (Schweizer et al. 2010,  2014). 
We next carried out frequency domain analysis of the HRV. As shown in Figure 5j, k, and l, we divided 
the HRV spectra into 3 frequency ranges: high frequency (HF; 1.5-4 Hz), low frequency (LF; 0.4-1.5 Hz), 
and very low frequency (VLF; 0-0.4 Hz). In all frequencies, the power was drastically decreased in OEx 
mice (Figure 5k), whereas increased in KD mice (Figure 5l). These results are summarized in Figure 6b. 
Taken together, our findings strongly suggest that the response of the SAN to parasympathetic nerve input 
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is modified in both OEx and KD mice. 
 
Genetic manipulation of HCN4 expression modified bradycardia induced by vagal nerve stimulation 
In heart-specific HCN4-knockout mice, the bradycardia induced by carbachol injection was reportedly 
enhanced (Herrmann et al. 2007; Hoesl et al. 2008). However, it was reported that pharmacological 
effects on cardiac electrical activity did not fully mimic the effects of the direct autonomic nerve 
stimulations (Mantravadi et al. 2007). Therefore, we next stimulated the right cervical vagal nerve (CVN) 
with bipolar electrodes, and evaluated the contribution of HCN4 in the parasympathetic response. 
 In WTs, we stimulated CVN (10 V at 20 Hz), so that an ~50% reduction of HR was induced (top trace, 
Figure 7a). We then stimulated the CVN of OEx and KD mice using the same conditions. The magnitude 
of bradycardia was smaller in the OEx mice but was not significantly different from the WTs. In KD mice, 
however, CVN stimulation induced complete sinus pause, and the recovery from sinus pause was delayed 
after the termination of electrical stimulation (bottom trace, Figure 7a). In addition, the bradycardia 
response was completely inhibited by a pre-injection of atropine (i.p. 0.5 mg/kg) in all strains of mice. 
The basal HR of KD mice were significantly lower than those of WT and OEx under general anaesthesia 
(Figure 7b; 323.1±39.3 vs 457.2±25.9 beats/min).  
However, β-adrenergic acceleration of HR was maintained in KD mice; after injection of isoproterenol 
(ISP; i.p. 0.2 mg/kg), the HR of WT, KD, and OEx mice was not significantly different, as shown in 
Figure 6c. Under this condition, CVN stimulation revealed markedly different responses in the three 
strains of mice: WT showed a 70.3±2.9% decrease in HR (710.0±11.3 to 210.8±20.3 beats/min), whereas 
in OEx mice, the magnitude of bradycardia was significantly smaller (40.7±4.5%; 728.0±20 to 
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434.0±41.7 beats/min). Notably, CVN stimulation induced complete sinus pause in KD mice, even in this 
condition. 
In addition to the direct effect on SAN function via M2 muscarinic receptor, the parasympathetic nerve 
possesses accentuated antagonism on the β-adrenergic effect. Because the sympathetic nerve possesses 
background activity, we applied propranolol (5 mg/kg), and performed CVN stimulation to examine 
direct effect of the parasympathetic stimulation. As shown in Fig. 7d, propranolol slightly reduced control 
HRs in all strains. CVN stimulation induced complete sinus pause in KD, whereas WT and OEx showed 
similar magnitudes of bradycardia. 
These results suggested that appropriate level of HCN4 expression is mandatory to maintain normal 
parasympathetic response of SAN, acting as a “limiter” for bradycardia induced by potent 
parasympathetic nerve activity. 
 
Effect of acetylcholine on the spontaneous action potentials in PMCs isolated from WT, OEx, and KD 
mice 
 The effects of accentuated antagonism of acetylcholine (ACh) were reportedly complex even in an 
isolated heart preparation, because it contains sympathetic nerve endings and the parasympathetic 
ganglions (Cuevas et al. 1997; Brack et al. 2004; Merriam et al. 2004). In order to exclude the neural 
factors, we isolated single PMCs from SAN, and recorded spontaneous action potentials (SAP) of PMCs. 
Under this condition, we compared the negative chronotropic effect of ACh in the three strains of mutant 
mice (Figure 8a). In this experiment, the majority of PMCs isolated from KD mice showed irregular 
beating. We also selected PMCs based on their morphology and motility, excluding quiescent PMCs. 
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As summarized in Figure 8b, the firing rates (FR) were significantly slower in KD mice compared with 
the WTs in the control condition. The FR was not significantly different between OEx and WT mice, 
consistent with HR measurements in vivo (Figure 7b). ACh slowed FR in a dose-dependent manner 
(Figure 8c). At 3 nmol, PMCs of KD mice showed a significantly larger reduction in FR (KD vs WT; 
39.6±8.8% vs 20.4±4.4%). At 30 nmol, SAP was completely suppressed in the PMCs of WT and KD 
mice, whereas the PMCs of OEx mice still showed low frequency firing (OEx; 80.4±22.2 beats/min vs 
WT; 4.5±4.5 beats/min, KD; 0 beats/min). 
 The effects of ACh on diastolic depolarization rates (DDR) of SAPs are summarized in Figure 8d &e. In 
the absence of ACh, the DDR was slightly higher in OEx than in WT mice, although this difference was 
not statistically significant. Consistent with the firing rate, the DDR of KD myocytes was significantly 
lower than those of the WTs at 0, 3 and 30 nmol (Fig. 8e & f). These results indicated that the ACh 
response of single PMCs was enhanced in the KD mice but attenuated in the OEx mice. 
 In Fig. 9, we next examined the accentuated antagonism of ACh in single PMCs. As shown in Fig. 9a, 
we first applied 100 nmol ISP to the PMCs isolated from WT, OEx and KD mice. Notably, PMCs of KD 
showed stable SAPs in the presence of -adrenergic stimulation, which well agreed with the previous 
reports (Herrmann et al. 2007). The control FR was not significantly different between WT, OEx and KD 
mice. In contrast, the magnitudes of ACh effects were profoundly affected by the difference of expression 
levels of HCN4 (Fig. 9b & c): At 20 nmol ACh, the PMCs of KD mice showed a significantly larger 
reduction in FR (KD vs WT; 82.1±7.1% vs 28.2±7.1%), whereas in the PMCs of OEx, the inhibition was 
significantly smaller (OEx, 7.8±4.2%). At 50 nmol, the SAP was almost completely suppressed in the 
PMCs of WT and KD mice (WT, 95.2±5.1%; KD, 99.9±4.4%), whereas the magnitude of the inhibition 
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was 55.1±5.1% in the PMCs of OEx. Similar tendencies were found in the effects of ACh on DDR (Fig. 9 
d &e). 
 
The effects of ACh on If current 
In rabbit PMCs, ACh reportedly inhibited If in basal condition, and thereby slowed SAP (DiFrancesco et 
al. 1989). We therefore examined the effects of 300 nM ACh which completely inhibit SAPs, on If 
currents in our system. As evident from Figure 9a-c, traces of If in the presence (red line) and absence 
(black line) of ACh were almost superimposable. As shown in Figure 9d-f, the voltage-dependent 
activation curves were not significantly different in the presence () and absence () of ACh, in all 
strains of transgenic mice. Similar finding was also reported in pregnant mice (El Khoury et al. 2013). 
Unlike in rabbit SAN, these results may also support the notion that If current did not expedite, but 
attenuate the parasympathetic response of murine SAN. 
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Discussion 
The present study demonstrated for the first time, that phenotypic changes in SAN function induced by 
conditional overexpression of HCN4 channels; genetic overexpression of HCN4 attenuated the 
parasympathetic response of the SAN and reduced the HRV. Furthermore, we have provided direct 
evidence that HCN4 channels prevent excessive bradycardia induced by potent parasympathetic nerve 
activity. We concluded that HCN4 channels played a protective role in parasympathetic regulation. The 
cAMP-dependent activation of HCN4 channels appeared to enhance this protective effect, rather than 
expediting sympathetic response of the SAN. 
In this study, HCN4 channels were globally overexpressed or knocked-down, including in the central 
nervous system (CNS). Presently, the physiological functions of HCN4 in the CNS remain unclear (Biel 
et al. 2009). As shown in the present study, the modifications of parasympathetic response observed in 
single PMCs were consistent with the phenotypic changes in vivo. Therefore, it seems safe to conclude 
that alterations in HR regulation in OEx and KD mice are attributable to the SAN, rather than the CNS.  
All members of the HCN channel family possess a cyclic nucleotide-binding motif at their C-terminal. 
During β-adrenergic stimulation, cAMP binds to this motif and increases the amplitude of the If by 
shifting the voltage-dependent activation curves of HCN2 and HCN4 in a positive direction (Biel et al. 
2009; Liao et al. 2010; El Khoury et al. 2013). Due to this property, HCN channels have been thought to 
play a critical role in the positive chronotropic effect of β-adrenergic stimulation (DiFrancesco, 2010) 
However, genetic ablation of cAMP sensitivity of HCN4 as well as transgenic overexpression of mutant 
HCN4 (HCN4-573X-Tg) that produces dominant negative suppression of cAMP sensitivity in 
heteromeric HCN channels did not inhibit β-adrenergic acceleration of the HR (Harzheim et al. 2008; 
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Alig et al. 2009). A similar phenotype was also reported in a patient carrying an HCN4 mutation that 
lacked cAMP-sensitivity (Schweizer et al. 2010). β-adrenergic chronotropic effect may be mainly 
attributable to Ca2+ clock mechanism and the up-regulation of D- & L-type Ca2+ channels (Lakatta et al. 
2010; Mesirca et al. 2015). 
In the SAN, the basal cAMP level may be high due to the ligand-free constitutive activity of the 
β2-adrenergic receptors that co-localize with HCN4 channels (Zhou et al. 2000; Barbuti et al. 2007; 
Greene et al. 2012). Basal cAMP may be required for maintaining the basal function of HCN channels 
because sinus arrhythmia was observed in transgenic mice in which the If lacked cAMP-sensitivity 
(Harzheim et al. 2008; Alig et al. 2009). Therefore, similar to “accentuated antagonism”, stimulation of 
muscarinic M2 receptors may regulate the If by inhibiting basal cAMP production via the β-subunit of Gi 
proteins. In rabbit PMCs, low dose ACh reportedly decreased the amplitude of the If by shifting the 
activation curve in a negative direction in basal condition (DiFrancesco et al. 1989). ACh also decreased 
the firing rate of SANs at a similar concentration. Therefore, inhibition of the If, rather than activation of 
muscarinic K+ channels (IKACh), was suggested to play a pivotal role in bradycardia induced by M2 
muscarinic receptors (DiFrancesco et al. 1989; DiFrancesco, 2010). However, in mice PMCs, ACh did 
not reportedly inhibit the basal If (El Khoury et al. 2013). Likewise, we could not observe ACh-induced 
inhibition of the If in the basal condition (Figure 6). At present, we do not have a ready explanation for 
this difference; it might be due to species differences. In human, however, If seems to play similar 
antagonistic role against parasympathetic response: In the patients carrying loss-of-function mutation of 
HCN4, it was reported that RR-interval was profoundly prolonged at night during which the 
parasympathetic nerve activity was higher (Schweizer et al. 2014). This finding agreed well with the HR 
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histogram of HCN4-KD mice obtained in low activity period. 
In a ligand-free condition, spontaneous opening of IKACh reportedly contributed to the background 
outward conductance of rabbit PMCs (Ito et al. 1994). Genetic ablation of GIRK4 successfully rescued 
SAN dysfunction in transgenic mice overexpressing dominant negative non-conducting mutant 
(HCN4-AYA-Tg) and in knockout mice lacking Cav1.3 (Mesirca et al. 2014, 2016). This finding was 
most likely due to correcting an imbalance between the outward- and the inward currents underlying the 
pacemaker potential. The autonomic regulation of the HR was abnormal in GIRK4 knockout mice 
(GIRK4-/-) that lacked IKACh; HR variability in HF and LF ranges was reduced in GIRK4
-/- mice (Wickman 
et al. 1998). As shown in the present study, we found that overexpression of HCN4 also decreased the 
HRV in all frequency ranges. Taken together, the activation of the If in the SAN appears to counteract 
IKACh, and therefore decreases the HRV by buffering the parasympathetic response. 
In the cardiac hypertrophy, expression of foetal type ion channels including HCN4 was reportedly 
reactivated in the ventricle (Kuwahara & Nakao, 2011). In the SAN, however, pathological remodelling 
of ion channels remains poorly understood. A recent study has reported that physical training 
down-regulated HCN4 expression in the SAN and thereby induced bradycardia (D'Souza et al. 2014). 
Expression of HCN4 may be down-regulated with age (Huang et al. 2016). The expression of ion 
channels in the SAN may also be regulated by circadian rhythms (Yaniv & Lakatta, 2015). In the present 
study, we could successfully visualize HCN4-expressing cells with luciferin-luciferase reaction, which is 
widely used for promoter assays. Therefore, HCN4+/luc mice would be useful for quantitative evaluation of 
the remodelling of HCN4 expression in future studies. 
In the cardiac conduction system (CCS), the phenotypic effects of genetic silencing of HCN4 appear 
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controversial; Atrio-ventricular (AV) block was observed in heart-specific ic-HCN4-KO mice and in 
HCN4-AYA-Tg mice (Baruscotti et al. 2011; Mesirca et al. 2014). The QRS complex was also prolonged 
in HCN4-AYA-Tg mice (Mesirca et al. 2014), although in other ic-HCN4-KO mice and HCN4-KD mice, 
these parameters were not changed (Herrmann et al. 2007; Hoesl et al. 2008). Conversely, PR and QRS 
durations were not shortened in HCN4-OEx mice (Figure 2). It has recently been reported that 
tachycardia in pregnant mice was due to the increased expression of HCN2 in the SAN. The PR interval 
was also shorter in pregnant mice, although ion channel remodelling of the AV node has not yet been 
explored (El Khoury et al. 2013). The transgenic mouse overexpressing HCN2 specifically in the heart 
reportedly showed tachycardia, but PR and QRS durations were not shortened (Oshita et al. 2015). 
Presently, the reasons for these discrepancies remain unclear; electrophysiological mechanisms regulating 
conduction velocity in the CCS should be explored in future research. 
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Figure Legends 
Figure 1. Generation of HCN4-OEx, HCN4-KD mice and luminescence imaging of HCN4
+/Luc
. 
(a) Genetic structures of HCN4 knock-in mice. Upper panel: Schematic illustration of a genetic switch. 
tTA; tetracycline trans-activator followed by termination signal SV-40 polyA. TRE-CMV; 
tetracycline-responsive element fused with a cytomegalovirus minimal promoter. Lower panel: Firefly 
luciferase cDNA fused with GFP cDNA followed by SV-40 polyA. (b-d) Ex-vivo imaging of cardiac 
conduction system. Left panels; bright field. Right panels; luminescence imaging of the same preparations 
as left panels. The intensity of luminescence signal is shown by a pseudo colour spectrum. (b) The right 
atrium preparation. CT; crista terminalis. SVC; superior vena cava. IVC; inferior vena cava. Scale bar; 0.5 
mm. (c) The intraluminal surface of the right ventricle. Scale bar: 2 mm. (d) The intraluminal surface of 
the left ventricle. Scale bar: 2 mm. (e) In vivo luminescence imaging; left 2 male mice, HCN4+/luc; right 2 
male mice, WT littermates. Exposure time of luminescence imaging in (b-e) was 3 min. 
 
Figure2. Expression levels of HCN4 were altered in OEx and KD mice. 
(a) qPCR for mRNAs of HCN1, 2, 3, and 4 were obtained from the whole hearts of WT (n=4), OEx (n=4) 
and KD (n=4) mice. DOX was applied for 2 and 4 weeks, respectively. *P<0.05, ***P<0.001. (b) 
Representative Western blots for HCN4 and tubulin protein in the heart. 
 
Figure 3. If currents in WT, OEx, and KD pacemaker myocytes. (a) Representative PMCs isolated 
from HCN4+/luc mice. Right panel, bright field. Left panel, luminescence image taken by 5 min exposure. 
Note that luminescence signals were detectable only in “spindle shaped” myocytes. scale bar: 20 μm. (b) 
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Representative If traces activated by voltage steps from -60 mV to -140 mV (10 mV increment). The 
holding potential was -50 mV. The scale bar indicates current density (pA/pF). (c) IV curves of the If in 
WT (open circles; n=14), OEx (filled squares; n=19), and KD (grey triangles; n=17) mice. *P<0.05, 
***P<0.001. 
 
Figure 4. Telemetric ECG recordings and HR histograms of free-moving WT, OEx, and KD mice. 
(a) Representative ECG traces of WT, OEx, and KD mice. (b) Summary of ECG parameters. WT (white, 
n=3), OEx (blue, n=3), and KD (red, n=3) mice. (c) HR histograms of WT (grey, n=3) and OEx (blue, 
n=3) mice. A histogram was constructed for the 12-hr low activity period (right panel) and the 12-hr high 
activity period (left panel). Bin width is 10 beats/min. (d) HR histograms of WT (grey, n=3) and KD (red, 
n=3) mice. Same as in (c). 
 
Figure 5. Analysis of HRV in WT, OEx, and KD mice. (a-c) Representative RR-interval plots of (a) WT, 
(b) OEx and (c) KD mice during the low activity period. (d-f) Dot plot of the HR (beats/min) of (d) WT, 
(e) OEx, and (f) KD mice. The dotted arrows indicate the injection of atropine and propranolol. (g-i) 
Poincare plots of the RR intervals. (g) WT, (h) OEx, and (i) KD mice during low activity periods. (j-l) 
Representative power spectral density plots. (j) WT, (k) OEx, and (l) KD mice. Note that range of the 
ordinate axis of (l) is enlarged. The spectrum was divided into 3 frequency ranges. HF; high frequency 
band (1.5-4 Hz). LF; low frequency band (0.5-1.5 Hz). VLF; very low frequency band (0-0.5 Hz). 
 
Figure 6. Summary of time domain analysis and frequency domain analysis. (a) Time domain RR 
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interval variability parameters of WT, OEx, and KD mice. The standard deviation of all normal RR 
intervals in the sinus rhythm (SDNN) and the square root of the mean of the squared differences between 
successive normal RR intervals (RMSSD) were calculated from a 2-hr recording during the low activity 
period. (b) Frequency domain analysis of the heart rate variability in WT, OEx, and KD mice. HRV was 
calculated during the low activity period. HF; high frequency band (1.5-4 Hz). LF; low frequency band 
(0.5-1.5 Hz). VLF; very low frequency band (0-0.5 Hz). *P<0.05, **P<0.01, ***P<0.001, n=3 in each 
group. 
 
Figure 7. Reduction of the HR induced by cervical vagal nerve stimulation (CVNS). 
(a) Representative ECG traces of WT, OEx, KD mice pre/post CVNS. The box indicates the duration of 
CVNS. Note that electrical artefacts were recorded in ECGs during this period. The arrows indicate R 
waves overlapping the artefacts. (b) Summary of the HR reduction induced by CVNS. ; WT (n=4). ; 
OEx (n=4). ; KD (n=4). (c) HR reduction by CVNS in the presence of ISP. Symbols are the same as in 
(b). (d) HR reduction by CVNS in the presence of Propranolol (5 mg/kg). *P <0.05, **, ++ P <0.01, *** 
P<0.001. 
 
Figure 8. Effects of ACh on the SAPs of single PMCs isolated from WT, OEx and KD mice. 
(a) The effects of the cumulative application of ACh on SAPs of PMCs isolated from WT (top), OEx 
(middle), and KD (bottom) mice. (b-e) The relationship between ACh concentration and (b) FR 
(beats/min), (c) %reduction of FR. (d) DDR (mV/s), and (e) %reduction of DDR. ; WT (n=11). ; OEx 
(n=11). ; KD (n=11). %reduction was calculated by normalizing each value by that in 0 nmol ACh. * 
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P<0.05, †† P<0.01, *** P<0.001.  
 
Figure 9. Effects of ACh with background ISP stimulation on the SAPs of single PMCs isolated 
from WT, OEx and KD mice. 
(a) The effects of the cumulative application of ACh in the presence of 100nM ISP. (b-e) The relationship 
between ACh concentration and (b) FR (beats/min), (c) %reduction of FR. (d) DDR (mV/s), and 
(e) %reduction of DDR, in the presence of ISP, respectively. %reduction was calculated by normalizing 
each value by that in 0 nmol ACh. ; WT (n=7). ; OEx (n=8). ; KD (n=8), * , † P<0.05, ***, ††† 
P<0.001.  
 
Figure 10. The effects of ACh on If currents of WT, OEx and KD PMCs. 
(a-c) If was activated by 2-step voltage pulses to -100 mV and -150 mV. The holding potential was -50 
mV. WT (a), OEx (b) and KD (c). The black traces indicate If in the control condition, and the red traces, 
in the presence of 300 nmol ACh. (d-f) The voltage-dependent activation curves of If in (d) WT, (e) OEx 
and (f) KD. ; control, ; in the presence of 300 nmol ACh (n = 6 in each experiment). The values of 
V1/2 (control vs ACh) were; WT, -95.2±3.2 mV vs -98.7±2.9 mV; OEx, -97.5±1.9 mV vs -101.5±1.8 mV; 
KD, -93.3±1.6 mV vs -99.1±1.6 mV.  
 
Table 1. Microarray analysis of transcripts potentially engaged in the regulation of pacemaker 
potential in SAN tissue. Fold changes of the WT vs OEx and WT vs KD mice are shown. The negative 
values indicate that the amounts of transcripts were less than those of WTs. None of the transcripts were 
significantly down-regulated or up-regulated. 
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Public Gene IDs  Gene Symbol Fold-change WT vs. OEx  
Fold-change  
WT vs. KD 
 NM_001164325  Trpm7 -1 1.11 
 NM_001253860  Scn5a -1.4 -1.17 
 NM_001159533  Cacna1c -1.24 -1.32 
 NM_001083616  Cacna1d -1.18 -1.29 
 NM_001112813  Cacna1g -1.06 -1.42 
 NM_001163691  Cacna1h -1.29 -1.31 
 NM_001304810  Kcnj3 -1.25 -1.25 
 NM_001025584  Kcnj6 -1.16 -1.13 
 NM_008429  Kcnj9 -1.05 -1 
 NM_010605  Kcnj5 -1.06 -1.15 
 NM_008434  Kcnq1 -1.17 -1.1 
 NM_001294162  Kcnh2 -1.24 -1.12 
 NM_001112798  Slc8a1 -1.11 -1.18 
 NM_007504  Atp2a1 -1.31 -1.16 
 NM_001110140  Atp2a2 -1.05 -1.05 
 NM_009109  Ryr1 -1.11 -1.09 
 NM_023868  Ryr2 -1.28 -1.26 
 NM_009813  Casq1 1.15 -1.02 
 NM_009814  Casq2 -1.23 -1.08 
 NM_001174053  Camk2b -1.05 -1.2 
 NM_001112697  Chrm1 -1.09 -1.12 
 NM_203491  Chrm2 -1.26 -1.27 
 NM_001282061  Rgs6 -1.09 -1.17 
 NM_001284380  Adra1b -1.35 -1.43 
 NM_001271759  Adra1a 1.05 1.15 
 NM_025331  Gng11 1.01 1.1 
